Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals - GlobalData

Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals - GlobalData
Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals
Published Sep 01, 2016
97 pages — Published Sep 01, 2016
Price US$ 1,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

  
Source:
Document ID
GDPH0500MD
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents210
  1.1 List of Tables53
  1.2 List of Figures84
2 Pharmaceuticals &Healthcare, Global, Deal Summary129
  2.1 Pharmaceuticals &Healthcare, Global, Deal Analysis, July 2016122
  2.2 Pharmaceuticals &Healthcare, Global, Major Deals, July 2016141
    2.2.1 Teva Pharma Raises USD15 Billion in Public Offering of Notes141
    2.2.2 Teva Pharma Raises USD4.4 Billion in Additional Public Offering of Notes151
    2.2.3 Celgene Enters into Agreement with Jounce Therapeutics151
    2.2.4 Galenica to Acquire Relypsa for USD1.53 Billion in Tender Offer161
    2.2.5 AstraZeneca to Enter into Co-Marketing Agreement with Aspen172
  2.3 Pharmaceuticals &Healthcare, Global, by Type, Number of Deals, July 2016191
  2.4 Pharmaceuticals &Healthcare, Global, by Type, Deal Values, July 2016201
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type2122
  3.1 Pharmaceuticals &Healthcare, Global, M&A, July 2016211
    3.1.1 Top M&A Deals in July 2016221
    3.1.2 Pharmaceuticals &Healthcare, Global, M&A Deals by Therapy Area, February 2016 July 2016231
  3.2 Pharmaceuticals &Healthcare, Global, Equity Offering Deals, July 2016241
    3.2.1 Top Equity Offering Deals in July 2016251
    3.2.2 Pharmaceuticals &Healthcare, Global, Equity Offering Deals by Therapy Area, February 2016 July 2016261
  3.3 Pharmaceuticals &Healthcare, Global, Private Equity and Venture Capital Deals, July 2016271
    3.3.1 Top PE/VC Deals in July 2016281
    3.3.2 Pharmaceuticals &Healthcare, Global, PE/VC by Therapy Area, July 2016291
    3.3.3 Pharmaceuticals &Healthcare, Global, Venture Capital Deals by Stage of Financing, July 2016301
    3.3.4 Pharmaceuticals &Healthcare, Global, Top Venture Financing Firms, February 2016 July 2016311
    3.3.5 Pharmaceuticals &Healthcare, Global, Top VC Backed Companies, February 2016 July 2016321
  3.4 Pharmaceuticals &Healthcare, Global, Partnership Deals, July 2016332
  3.5 Pharmaceuticals &Healthcare, Global, Partnership Deals by Therapy Area, February 2016 July 2016351
  3.6 Pharmaceuticals &Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), July 2016361
    3.6.1 Pharmaceuticals &Healthcare, Global, Top Partnership Deals by Payment Mode, July 2016371
  3.7 Pharmaceuticals &Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2016 July 2016382
  3.8 Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, Number Of Deals, February 2016 July 2016401
  3.9 Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), February 2016 July 2016411
  3.10 Pharmaceuticals &Healthcare, Global, Partnership Deals by Phase, by Upfront &Milestone Payments and Deal Values (US$ m), February 2016 July 2016421
4 Pharmaceuticals &Healthcare, Global, Licensing Agreements, July 20164313
  4.1 Pharmaceuticals &Healthcare, Global, Licensing Agreements, July 2016432
  4.2 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2016452
  4.3 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), February 2016 July 2016472
  4.4 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), February 2016 July 2016492
  4.5 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), February 2016 July 2016512
  4.6 Pharmaceuticals &Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), February 2016 July 2016531
    4.6.1 Pharmaceuticals &Healthcare, Global, Top Licensing Agreements by Deal Value, July 2016541
    4.6.2 Pharmaceuticals &Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, July 2016551
    4.6.3 Pharmaceuticals &Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, July 2016551
5 Pharmaceuticals &Healthcare, Global, Deal Summary by Therapy Area5621
  5.1 Pharmaceuticals &Healthcare, Global, Oncology Deals, July 2016561
    5.1.1 Oncology Deals of the Month572
  5.2 Pharmaceuticals &Healthcare, Global, Central Nervous System Deals, July 2016591
    5.2.1 Central Nervous System Deals of the Month601
  5.3 Pharmaceuticals &Healthcare, Global, Infectious Disease Deals, July 2016611
    5.3.1 Infectious Diseases Deals of the Month622
  5.4 Pharmaceuticals &Healthcare, Global, Cardiovascular Deals, July 2016641
    5.4.1 Cardiovascular Deals of the Month652
  5.5 Pharmaceuticals &Healthcare, Global, Immunology Deals, July 2016671
    5.5.1 Immunology Deals of the Month683
  5.6 Pharmaceuticals &Healthcare, Global, Gastrointestinal Deals, July 2016711
    5.6.1 Gastrointestinal Deal of the Month723
  5.7 Pharmaceuticals &Healthcare, Global, Metabolic Disorders, Deals, July 2016751
    5.7.1 Metabolic Disorders Deal of the Month761
6 Deal Summary by Geography7713
  6.1 Pharmaceuticals &Healthcare, North America Deals, July 2016771
    6.1.1 North America Deals of the Month783
  6.2 Pharmaceuticals &Healthcare, Europe, Deals, July 2016811
    6.2.1 Europe Deals of the Month822
  6.3 Pharmaceuticals &Healthcare, Asia-Pacific, Regional Deals, July 2016841
    6.3.1 Asia-Pacific Deals of the Month852
  6.4 Pharmaceuticals &Healthcare, Rest of the World, Deals, July 2016871
    6.4.1 Rest of the World Deals of the Month882
7 Pharmaceuticals &Healthcare, Global, Top Financial Advisors904
  7.1 Pharmaceuticals &Healthcare, Global, Top Financial Advisors, M&A, February 2016 July 2016902
  7.2 Pharmaceuticals &Healthcare, Global, Top Financial Advisors, Equity Offerings, February 2016 July 2016922
8 Further Information944
  8.1 Methodology941
  8.2 About GlobalData951
  8.3 Disclosure information951
  8.4 Disclaimer962

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals" Sep 01, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData/Partnerships-Licensing-Investments-and-M-A-Deals-and-Trends-for-July-2016-in-Pharmaceuticals-2085-23558>
  
APA:
GlobalData. (2016). Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals Sep 01, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/Partnerships-Licensing-Investments-and-M-A-Deals-and-Trends-for-July-2016-in-Pharmaceuticals-2085-23558>
  
US$ 1,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.